SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-054237
Filing Date
2013-07-12
Accepted
2013-07-12 16:02:37
Documents
12
Period of Report
2013-07-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-16219_68k.htm 8-K 43773
2 EX-1.1 a13-16219_6ex1d1.htm EX-1.1 373178
3 EX-1.2 a13-16219_6ex1d2.htm EX-1.2 379420
4 EX-5.1 a13-16219_6ex5d1.htm EX-5.1 18870
5 EX-5.2 a13-16219_6ex5d2.htm EX-5.2 25039
6 EX-10.1 a13-16219_6ex10d1.htm EX-10.1 31607
7 EX-99.1 a13-16219_6ex99d1.htm EX-99.1 12926
8 GRAPHIC g162196kgi001.jpg GRAPHIC 1248
9 GRAPHIC g162196kgi002.gif GRAPHIC 9408
10 GRAPHIC g162196kei001.jpg GRAPHIC 1248
11 GRAPHIC g162196kei002.jpg GRAPHIC 7906
12 GRAPHIC g162196mmi001.jpg GRAPHIC 13201
  Complete submission text file 0001104659-13-054237.txt   932217
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 13966065
SIC: 2834 Pharmaceutical Preparations